Skip to main content

Bruker Value Stock - Dividend - Research Selection

Bruker

ISIN: US1167941087 , WKN: 813534

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Is Bruker (BRKR) Fairly Valued After Its 52 Week High?

2026-08-05
Bruker stock has had a strong run over the past year while the latest valuation work, including a Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks, still points to the shares trading at a discount to those fundamentals. Bruker has returned 57.6% over the past year, which puts extra focus on whether that share price move is now in line with the company’s underlying value. Recent acquisitions in life sciences, including the DISQVER metagenomic sequencing platform,...

Carillon Chartwell Mid Cap Value Fund Q2 2026 Portfolio Review

2026-08-05
ON Semiconductor designs and manufactures power and sensing semiconductors for automotive, industrial, and data center applications.

Citigroup Maintains Neutral on Bruker, Lowers Price Target to $53

2026-08-05
Citigroup analyst Brendan Digan maintains Bruker (NASDAQ:BRKR) with a Neutral and lowers the price target from $60 to $53.

Weak Growth In Its Primary Market Continues To Weigh Heavily On Bruker Shares

2026-08-05
Bruker Corporation faces ongoing headwinds from weak academic/government funding that has compressed growth. Read more on BRKR stock here.

Bruker (BRKR) Is Down 20.0% After Goodwill Impairment-Fueled Q2 Loss Despite Higher Sales

2026-08-05
Bruker Corporation’s Q2 2026 results, released on August 4, 2026, showed sales rising to US$838.5 million from US$797.4 million year over year, but a goodwill and intangible asset impairment charge of US$134.9 million and other items drove a net loss of US$52 million versus prior-year net income. The company reaffirmed a path to growth by guiding Fiscal Year 2026 revenues to US$3.54–US$3.57 billion, implying 3%–4% reported growth over 2025, while targeting cost savings and maintaining its...

Bruker (BRKR) Could Be 16% Below Fair Value On Q2 Results And 2026 Guidance

2026-08-05
Bruker (BRKR) just updated its 2026 revenue guidance alongside second quarter results, pairing a forecast of US$3.54b to US$3.57b in sales with a sizeable goodwill impairment and a reported quarterly net loss. See our latest analysis for Bruker. The sharp 1 day share price decline of 21.79% left Bruker trading at US$50.30, even though the 1 year total shareholder return is 57.62% and the 5 year total shareholder return is down 38.05%. This points to strong recent momentum but a weaker longer...

Bruker Corporation Q2 2026 Earnings Call Summary

2026-08-04
Moby summary of Bruker Corporation's Q2 2026 earnings call

Bruker Corp (BRKR) (Q2 2026) Earnings Call Highlights: Organic Growth Returns, Margins Surge, ...

2026-08-04
Bruker Corp (BRKR) posts 5.2% revenue growth and 53% EPS jump, driven by strong biopharma and semiconductor orders despite U.S. academic weakness.

Bruker Corporation 2026 Q2 - Results - Earnings Call Presentation

2026-08-04
2026-08-04. The following slide deck was published by Bruker Corporation in conjunction with their 2026 Q2 earnings call.

Bruker Reports Second-Quarter 2026 Results as Scientific Instruments Bookings Accelerate

2026-08-04
Bruker (NASDAQ:BRKR) returned to organic revenue growth in the second quarter, posted stronger bookings across its Scientific Instruments business, and maintained its earnings outlook while adjusting guidance for currency and tax changes. Key Investor TakeawaysBruker (NASDAQ:BRKR) returned to organic revenue growth, with second-quarter revenue increasing 5.